No Data
Bicara leads the way in fundraising for the IPO of a US biotechnology company, raising 0.703 billion US dollars.
Three US biotechnology companies sold stocks in their initial public offering (IPO) on Thursday, which is an encouraging sign for this recently struggling industry. Bicara Therapeutics Inc. expanded its IPO and issued 1.75 million shares of stocks, raising $315 million at a price range of $18 per share. Regulatory filings show that the company increased the number of stocks on Wednesday. MBX Biosciences Inc. raised $163.2 million in its expanded IPO at $16 per share.
Express News | Mbx Biosciences Announces Pricing of Initial Public Offering
MBX Biosciences Announces Pricing of Initial Public Offering
The IPO Buzz: MBX Biosciences (MBX) Prices Upsized IPO at $16 – High End
Will MBX Biosciences (NASDAQ:MBX) Spend Its Cash Wisely?
Mbx Biosciences, Inc To Start Trading Tomorrow
No Data
No Data